| SANA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SANA market cap history going back to 2/4/2021:
Also see: SANA Shares Outstanding History and SANA YTD Return |
As of 4/30/2026 Sana Biotechnology has a market cap of 915.58 million. Investors often follow the SANA market cap history to compare the size of the company over time.
This page shows SANA market capitalization trends over time, with 23 market cap datapoints presented, dating back to 2/4/2021.

| SANA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SANA market cap history going back to 2/4/2021:
Also see: SANA Shares Outstanding History and SANA YTD Return |
| SANA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
SANA Historical Market Cap: -30.52% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| SANA Stock Price Chart |
| About Sana Biotechnology Inc |
| Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune and central nervous system disorders. It develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of therapeutic areas. Its pipeline includes SC291, SC262, SC255, C379, SC451 and UP421. It is applying its hypoimmune technology to donor derived T cells to be used as allogeneic cell therapies for hematologic malignancies. We show 23 historical shares outstanding datapoints in our SANA shares outstanding history coverage, used to compute SANA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SANA market cap history over the course of time is important for investors interested in comparing SANA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SANA versus a peer is one thing; comparing SANA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SANA can fluctuate over the course of history. With this page we aim to empower investors researching SANA by allowing them to research the SANA market cap history. |
| SANA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| SANA Share Performance |
| Market Cap Peers |
| Sana Biotechnology (SANA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SAVA Market Cap History SBFM Market Cap History SBPH Market Cap History SBTX Market Cap History SCPH Market Cap History SCPS Market Cap History SCTL Market Cap History SCYX Market Cap History SDC Market Cap History SDGR Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.